Allosteric effects of cardiac troponin TNT1 mutations on actomyosin binding: a novel pathogenic mechanism for hypertrophic cardiomyopathy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Archives of Biochemistry and Biophysics

• Publication date

  2014-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.abb.2014.01.016PMID 24480310PMCID PMC4761439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conserved Asp-137 Is Important for both Structure and Regulatory Functions of Cardiac α-Tropomyosin (α-TM) in a Novel Transgenic Mouse Model Expressing α-TM-D137L*

  2013cited by this paper
• HCM-linked ∆160E cardiac troponin T mutation causes unique progressive structural and molecular ventricular remodeling in transgenic mice.

  2013cited by this paper
• Correlation of Molecular and Functional Effects of Mutations in Cardiac Troponin T Linked to Familial Hypertrophic Cardiomyopathy

  2012cited by this paper
• Long-Term Outcomes in Hypertrophic Cardiomyopathy Caused by Mutations in the Cardiac Troponin T Gene

  2012cited by this paper
• Thin Filament Mutations : Developing an Integrative Approach to a Complex Disorder

  2011cited by this paper
• Troponin T is essential for sarcomere assembly in zebrafish skeletal muscle

  2011cited by this paper
• Thin Filament Mutations: Developing an Integrative Approach to a Complex Disorder

  2011cited by this paper
• Stochastic bistability and bifurcation in a mesoscopic signaling system with autocatalytic kinase.

  2010cited by this paper
• Myofibrillogenesis in the developing zebrafish heart: A functional study of tnnt2.

  2009cited by this paper
• Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy

  2009cited by this paper
• Targeted disruption of the cardiac troponin T gene causes sarcomere disassembly and defects in heartbeat within the early mouse embryo.

  2008cited by this paper
• Genetic Basis of Hypertrophic Cardiomyopathy: From Bench to the Clinics

  2007cited by this paper
• Computational Characterization of Mutations in Cardiac Troponin T Known to Cause Familial Hypertrophic Cardiomyopathy.

  2007cited by this paper
• Independent FHC-related cardiac troponin T mutations exhibit specific alterations in myocellular contractility and calcium kinetics.

  2007cited by this paper
• An atomic model of the thin filament in the relaxed and Ca2+-activated states.

  2006cited by this paper
• Hypertrophic Cardiomyopathy

  2006cited by this paper
• Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation.

  2005cited by this paper
• Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice.

  2005cited by this paper
• Role of troponin T in disease

  2004cited by this paper
• Familial Hypertrophic Cardiomyopathy Mutations from Different Functional Regions of Troponin T Result in Different Effects on the pH and Ca2+ Sensitivity of Cardiac Muscle Contraction*

  2004cited by this paper
• Phosphorylation or Glutamic Acid Substitution at Protein Kinase C Sites on Cardiac Troponin I Differentially Depress Myofilament Tension and Shortening Velocity*

  2003cited by this paper
• Identification of a Functionally Critical Protein Kinase C Phosphorylation Residue of Cardiac Troponin T *

  2003cited by this paper
• Folding and Function of the Troponin Tail Domain

  2003cited by this paper
• Structure of the core domain of human cardiac troponin in the Ca2+-saturated form

  2003cited by this paper
• Cardiac troponin T is essential in sarcomere assembly and cardiac contractility

  2002cited by this paper
• Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region.

  2001cited by this paper
• Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.

  2001cited by this paper
• Functional consequences of the deletion mutation deltaGlu160 in human cardiac troponin T.

  2000cited by this paper
• Functional Consequences of the Deletion Mutation ΔlGlul6O in Human Cardiac Troponin T

  2000cited by this paper
• Altered Regulation of Cardiac Muscle Contraction by Troponin T Mutations That Cause Familial Hypertrophic Cardiomyopathy*

  2000cited by this paper
• Tropomyosin positions in regulated thin filaments revealed by cryoelectron microscopy.

  1999cited by this paper
• Roles for the Troponin Tail Domain in Thin Filament Assembly and Regulation

  1999cited by this paper
• Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.

  1999cited by this paper
• A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy.

  1998cited by this paper
• Calcium regulation of skeletal muscle thin filament motility in vitro.

  1997cited by this paper
• Steric-model for activation of muscle thin filaments.

  1997cited by this paper
• Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy.

  1996cited by this paper
• Calcium regulation of thin filament movement in an in vitro motility assay.

  1996cited by this paper
• Regulation of the cross-bridge transition from a weakly to strongly bound state in skinned rabbit muscle fibers.

  1995cited by this paper
• Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.

  1995cited by this paper
• Regulation of the interaction between actin and myosin subfragment 1: evidence for three states of the thin filament.

  1993cited by this paper
• Factors affecting movement of F-actin filaments propelled by skeletal muscle heavy meromyosin.

  1992cited by this paper
• Assays for actin sliding movement over myosin-coated surfaces.

  1991cited by this paper
• Myosin step size. Estimation from slow sliding movement of actin over low densities of heavy meromyosin.

  1990cited by this paper
• Fluorescent actin filaments move on myosin fixed to a glass surface.

  1986cited by this paper
• ADP dissociation from actomyosin subfragment 1 is sufficiently slow to limit the unloaded shortening velocity in vertebrate muscle.

  1985cited by this paper
• ATP-dependent movement of myosin in vitro: characterization of a quantitative assay

  1984cited by this paper
• [7] Preparation of myosin and its subfragments from rabbit skeletal muscle

  1982cited by this paper
• Preparation and identification of alpha- and beta-tropomyosins.

  1982cited by this paper
• Preparation of myosin and its subfragments from rabbit skeletal muscle.

  1982cited by this paper

• Motility Assay to Probe the Calcium Sensitivity of Myosin and Regulated Thin Filaments.

  2024cites this paper
• Arg92Leu-cTnT Alters the cTnC-cTnI Interface Disrupting PKA-Mediated Relaxation

  2024cites this paper
• Structural dynamics of the intrinsically disordered linker region of cardiac troponin T

  2024cites this paper
• The HCM – Linked Mutation Arg92Leu in TNNT2 Allosterically Alters the cTnC – cTnI Interface and Disrupts the PKA-mediated Regulation of Myofilament Relaxation

  2023cites this paper
• Experimental Model of Cardiotoxicity

  2022cites this paper
• Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics

  2022cites this paper
• Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations

  2022cites this paper
• Molecular Mechanisms of Pathologies of Skeletal and Cardiac Muscles Caused by Point Mutations in the Tropomyosin Genes

  2020cites this paper
• Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic TNNT2 Gene Variants

  2020cites this paper
• FRET-based analysis of the cardiac troponin T linker region reveals the structural basis of the hypertrophic cardiomyopathy-causing Δ160E mutation

  2019influential citation
• Moving beyond simple answers to complex disorders in sarcomeric cardiomyopathies: the role of integrated systems

  2019cites this paper
• Impact of Variant Reclassification in the Clinical Setting of Cardiovascular Genetics

  2017cites this paper
• Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models

  2017cites this paper
• Molecular mechanisms and structural features of cardiomyopathy-causing troponin T mutants in the tropomyosin overlap region

  2017cites this paper
• Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility.

  2016cites this paper
• Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype

  2016cites this paper
• The genetic landscape of cardiomyopathy and its role in heart failure.

  2015cites this paper